APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

Selected research

Market Analysis & Forecast

Global Transcatheter Aortic Valve Replacement (TAVR) Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchTranscatheter Aortic Valve Replacement (TAVR) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Transcatheter Aortic Valve Replacement (TAVR) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Transcatheter Aortic Valve Replacement (TAVR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transcatheter Aortic Valve Replacement (TAVR) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Transcatheter Aortic Valve Replacement (TAVR) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.

East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.

Read the full market overview

In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.

Report Includes

This report presents an overview of global market for Transcatheter Aortic Valve Replacement (TAVR), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transcatheter Aortic Valve Replacement (TAVR), also provides the revenue of main regions and countries. Of the upcoming market potential for Transcatheter Aortic Valve Replacement (TAVR), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transcatheter Aortic Valve Replacement (TAVR) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transcatheter Aortic Valve Replacement (TAVR) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Transcatheter Aortic Valve Replacement (TAVR) revenue, projected growth trends, production technology, application and end-user industry.

Transcatheter Aortic Valve Replacement (TAVR) Segment by Company

Edwards Lifesciences

Medtronic

Abbott

Boston Scientific

Meril Life Sciences

Venus Medtech

Bracco (HLT)

JenaValve Technology

Suzhou Jiecheng Medical Technology Co.

Peijia Medical

Transcatheter Aortic Valve Replacement (TAVR) Segment by Type

Transfemoral Approach

Transapical Approach

Others

Transcatheter Aortic Valve Replacement (TAVR) Segment by Application

Aortic Stenosis

Aortic Regurgitation

Others

Transcatheter Aortic Valve Replacement (TAVR) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Aortic Valve Replacement (TAVR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Aortic Valve Replacement (TAVR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Aortic Valve Replacement (TAVR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcatheter Aortic Valve Replacement (TAVR) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Transfemoral Approach Major Player Table 3. Transapical Approach Major Player Table 4. Others Major Player Table 5. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Aortic Stenosis Major Player Table 7. Aortic Regurgitation Major Player Table 8. Others Major Player Table 9. Transcatheter Aortic Valve Replacement (TAVR) Industry Trends Table 10. Transcatheter Aortic Valve Replacement (TAVR) Industry Drivers Table 11. Transcatheter Aortic Valve Replacement (TAVR) Industry Opportunities and Challenges Table 12. Transcatheter Aortic Valve Replacement (TAVR) Industry Restraints Table 13. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Region (2021-2026) Table 16. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Region (2027-2032) Table 18. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Players (2021-2026) Table 20. Global Transcatheter Aortic Valve Replacement (TAVR) Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Transcatheter Aortic Valve Replacement (TAVR) Key Players Headquarters & Area Served Table 22. Global Transcatheter Aortic Valve Replacement (TAVR) Players, Product Type & Application Table 23. Global Transcatheter Aortic Valve Replacement (TAVR) Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Transcatheter Aortic Valve Replacement (TAVR) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2021-2026) Table 30. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2027-2032) Table 31. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2021-2026) Table 35. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2027-2032) Table 36. Edwards Lifesciences Company Information Table 37. Edwards Lifesciences Business Overview Table 38. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 40. Edwards Lifesciences Recent Development Table 41. Medtronic Company Information Table 42. Medtronic Business Overview Table 43. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 45. Medtronic Recent Development Table 46. Abbott Company Information Table 47. Abbott Business Overview Table 48. Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 50. Abbott Recent Development Table 51. Boston Scientific Company Information Table 52. Boston Scientific Business Overview Table 53. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 55. Boston Scientific Recent Development Table 56. Meril Life Sciences Company Information Table 57. Meril Life Sciences Business Overview Table 58. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 60. Meril Life Sciences Recent Development Table 61. Venus Medtech Company Information Table 62. Venus Medtech Business Overview Table 63. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 65. Venus Medtech Recent Development Table 66. Bracco (HLT) Company Information Table 67. Bracco (HLT) Business Overview Table 68. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 70. Bracco (HLT) Recent Development Table 71. JenaValve Technology Company Information Table 72. JenaValve Technology Business Overview Table 73. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 75. JenaValve Technology Recent Development Table 76. Suzhou Jiecheng Medical Technology Co. Company Information Table 77. Suzhou Jiecheng Medical Technology Co. Business Overview Table 78. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 80. Suzhou Jiecheng Medical Technology Co. Recent Development Table 81. Peijia Medical Company Information Table 82. Peijia Medical Business Overview Table 83. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio Table 85. Peijia Medical Recent Development Table 86. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (US$ Million) & (2027-2032) Table 100. China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026) & (US$ Million) Table 101. China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032) & (US$ Million) Table 102. China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026) & (US$ Million) Table 103. China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Transcatheter Aortic Valve Replacement (TAVR) Image Figure 2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Transfemoral Approach Image Figure 5. Transapical Approach Image Figure 6. Others Image Figure 7. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Aortic Stenosis Image Figure 10. Aortic Regurgitation Image Figure 11. Others Image Figure 12. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size (US$ Million) & (2021-2032) Figure 13. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2021-2032) Figure 20. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2021-2032) Figure 23. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032) Figure 25. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032) Figure 26. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Country (2021-2032) Figure 27. United States Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032) Figure 32. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032) Figure 33. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Country (2021-2032) Figure 34. Germany Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032) Figure 44. China Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032) Figure 45. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032) Figure 47. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032) Figure 48. Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Region (2021-2032) Figure 49. Japan Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032) Figure 57. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032) Figure 58. SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Country (2021-2032) Figure 59. Brazil Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Transcatheter Aortic Valve Replacement (TAVR) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Transfemoral Approach
  • Transapical Approach
  • Others
Applications
  • Aortic Stenosis
  • Aortic Regurgitation
  • Others
Companies covered
  • Edwards Lifesciences
  • Medtronic
  • Abbott
  • Boston Scientific
  • Meril Life Sciences
  • Venus Medtech
  • Bracco (HLT)
  • JenaValve Technology
  • Suzhou Jiecheng Medical Technology Co.
  • Peijia Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transcatheter Aortic Valve Replacement (TAVR) Market by Type
  3. 1.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Transfemoral Approach
  5. 1.2.3 Transapical Approach
  6. 1.2.4 Others
  7. 1.3 Transcatheter Aortic Valve Replacement (TAVR) Market by Application
  8. 1.3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Aortic Stenosis
  10. 1.3.3 Aortic Regurgitation
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
  1. 2.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
  2. 2.2 Transcatheter Aortic Valve Replacement (TAVR) Industry Drivers
  3. 2.3 Transcatheter Aortic Valve Replacement (TAVR) Industry Opportunities and Challenges
  4. 2.4 Transcatheter Aortic Valve Replacement (TAVR) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Perspective (2021-2032)
  2. 3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Growth Trends by Region
  3. 3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2021-2026)
  5. 3.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Players
  2. 4.1.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Players (2021-2026)
  3. 4.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Transcatheter Aortic Valve Replacement (TAVR) Key Players Headquarters & Area Served
  7. 4.4 Global Transcatheter Aortic Valve Replacement (TAVR) Players, Product Type & Application
  8. 4.5 Global Transcatheter Aortic Valve Replacement (TAVR) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market CR5 and HHI
  11. 4.6.3 2025 Transcatheter Aortic Valve Replacement (TAVR) Tier 1, Tier 2, and Tier 3
5 Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type
  1. 5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2032)
  3. 5.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2021-2032)
6 Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application
  1. 6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2032)
  3. 6.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Edwards Lifesciences
  2. 7.1.1 Edwards Lifesciences Company Information
  3. 7.1.2 Edwards Lifesciences Business Overview
  4. 7.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  6. 7.1.5 Edwards Lifesciences Recent Developments
  7. 7.2 Medtronic
  8. 7.2.1 Medtronic Company Information
  9. 7.2.2 Medtronic Business Overview
  10. 7.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  12. 7.2.5 Medtronic Recent Developments
  13. 7.3 Abbott
  14. 7.3.1 Abbott Company Information
  15. 7.3.2 Abbott Business Overview
  16. 7.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  18. 7.3.5 Abbott Recent Developments
  19. 7.4 Boston Scientific
  20. 7.4.1 Boston Scientific Company Information
  21. 7.4.2 Boston Scientific Business Overview
  22. 7.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  24. 7.4.5 Boston Scientific Recent Developments
  25. 7.5 Meril Life Sciences
  26. 7.5.1 Meril Life Sciences Company Information
  27. 7.5.2 Meril Life Sciences Business Overview
  28. 7.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  30. 7.5.5 Meril Life Sciences Recent Developments
  31. 7.6 Venus Medtech
  32. 7.6.1 Venus Medtech Company Information
  33. 7.6.2 Venus Medtech Business Overview
  34. 7.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  36. 7.6.5 Venus Medtech Recent Developments
  37. 7.7 Bracco (HLT)
  38. 7.7.1 Bracco (HLT) Company Information
  39. 7.7.2 Bracco (HLT) Business Overview
  40. 7.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  42. 7.7.5 Bracco (HLT) Recent Developments
  43. 7.8 JenaValve Technology
  44. 7.8.1 JenaValve Technology Company Information
  45. 7.8.2 JenaValve Technology Business Overview
  46. 7.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  48. 7.8.5 JenaValve Technology Recent Developments
  49. 7.9 Suzhou Jiecheng Medical Technology Co.
  50. 7.9.1 Suzhou Jiecheng Medical Technology Co. Company Information
  51. 7.9.2 Suzhou Jiecheng Medical Technology Co. Business Overview
  52. 7.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  54. 7.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
  55. 7.10 Peijia Medical
  56. 7.10.1 Peijia Medical Company Information
  57. 7.10.2 Peijia Medical Business Overview
  58. 7.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  60. 7.10.5 Peijia Medical Recent Developments
8 North America
  1. 8.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue (2021-2032)
  2. 8.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2032)
  3. 8.2.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026)
  4. 8.2.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032)
  5. 8.3 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032)
  6. 8.4 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2032)
  7. 8.4.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026)
  8. 8.4.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032)
  9. 8.5 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032)
  10. 8.6 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  11. 8.6.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026)
  13. 8.6.3 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue (2021-2032)
  2. 9.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032)
  5. 9.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032)
  9. 9.5 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  11. 9.6.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue (2021-2032)
  2. 10.2 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2032)
  3. 10.2.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026)
  4. 10.2.2 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032)
  5. 10.3 China Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032)
  6. 10.4 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2032)
  7. 10.4.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026)
  8. 10.4.2 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032)
  9. 10.5 China Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue (2021-2032)
  2. 11.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032)
  5. 11.3 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032)
  9. 11.5 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  11. 11.6.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue (2021-2032)
  2. 12.2 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  11. 12.6.1 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst